iSpecimen Inc. (ISPC) income statement
ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 17, 2026Score 7/3045% below fair value
$0.53−0.06 (-10.57%)
Close on Nov 18, 2026Market cap $1.34MP/E –Yield –
iSpecimen Inc. financial ratios
See a number that looks wrong?